Virtual Presentation on NEXLETOL: A New, Oral, Nonstatin Therapy for Lowering LDL-C

Posted over 5 years ago by Deanna Harless, DNP, ACNP-BC, FNP-BC

This announcement has 3 attachments:

Attendee Invitation (NEXLETOL) (1008) April 30th 7pm (200 KB)

Attendee Invitation (NEXLETOL) (1009) May 5th 730pm (200 KB)

Attendee Invitation (NEXLETOL) (1010) May 7th 7pm (200 KB)

Hi Lake Charles Region: We were contacted by Fred Bennerscheidt regarding a new drug he is marketing. Since we are unable to get together due to COVID-19, he is offering a virtual presentation to our region.

There are 3 different dates that the virtual presentation will be given. You MUST register for the event. We are hopeful that everyone will find a convenient time.

Respectfully,

Dee Harless & Melissa Kramer

Lake Charles Co-Reps

A note from Fred:

I'd like to schedule a virtual meeting with you to discuss a newly approved LDL-C lowering treatment: NEXLETOL.1

Millions of patients with hypercholesterolemia still can’t reach their LDL-C goal, despite taking statins.

Now, there’s NEXLETOL: An oral, once-daily, nonstatin therapy that can help get many of your patients with ASCVD or HeFH closer to achieving their LDL-C goal.